Biorce — Series A · $52.5M

Biorce closed a $52.5M Series A (reported locally as roughly €43.8-44.3M) for its Aika AI platform that designs and runs clinical trials, described as the largest Series A ever in the Iberian healthtech ecosystem. Proceeds go to growing the team to 250 people and opening an R&D hub in Austin, Texas.

LeadDST Global Partners RoundSeries A Announced2 Feb 2026 CityBarcelona SectorHealthtech & Bio · Healthtech / AI for clinical trials Source

Something wrong? Suggest a correction →

The company

Investors 9

DST Global Partners
LeadRussia
Albert Nieto
Spain
Arthur Mensch
France
Endeavor Catalyst
endeavor.org
United States
Portugal
Nik Storonsky
United Arab Emirates
Norrsken VC
norrsken.vc
Sweden
Paulo Rosado
Portugal
YZR Capital
Germany

← All funding rounds

Start typing to search across everything.
↑↓ navigate↵ openesc close? shortcuts
Keyboard shortcuts
/ Ctrl K
Search
j k
Next or previous row
↵
Open the row
Ctrl ↵
Open it in a new tab
[ ]
Previous or next page
?
This list